Manipulation of a spider peptide toxin alters its affinity for lipid bilayers and potency and selectivity for voltage-gated sodium channel subtype 1.7.

The Journal of Biological Chemistry
Akello J AgwaChristina I Schroeder

Abstract

Huwentoxin-IV (HwTx-IV) is a gating modifier peptide toxin from spiders that has weak affinity for the lipid bilayer. As some gating modifier toxins have affinity for model lipid bilayers, a tripartite relationship among gating modifier toxins, voltage-gated ion channels, and the lipid membrane surrounding the channels has been proposed. We previously designed an HwTx-IV analogue (gHwTx-IV) with reduced negative charge and increased hydrophobic surface profile, which displays increased lipid bilayer affinity and in vitro activity at the voltage-gated sodium channel subtype 1.7 (NaV1.7), a channel targeted in pain management. Here, we show that replacements of the positively-charged residues that contribute to the activity of the peptide can improve gHwTx-IV's potency and selectivity for NaV1.7. Using HwTx-IV, gHwTx-IV, [R26A]gHwTx-IV, [K27A]gHwTx-IV, and [R29A]gHwTx-IV variants, we examined their potency and selectivity at human NaV1.7 and their affinity for the lipid bilayer. [R26A]gHwTx-IV consistently displayed the most improved potency and selectivity for NaV1.7, examined alongside off-target NaVs, compared with HwTx-IV and gHwTx-IV. The lipid affinity of each of the three novel analogues was weaker than that of gHwTx-IV, b...Continue Reading

References

Oct 1, 1994·Protein Science : a Publication of the Protein Society·P K PallaghyR S Norton
Apr 10, 2002·Neurology·T SugawaraK Yamakawa
Jun 17, 2005·Brain : a Journal of Neurology·S D Dib-HajjS G Waxman
Dec 15, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Fumimasa AmayaClifford J Woolf
Dec 15, 2006·Nature·James J CoxC Geoffrey Woods
Oct 17, 2007·The Journal of General Physiology·Mirela MilescuKenton J Swartz
Oct 24, 2007·Trends in Neurosciences·Sulayman D Dib-HajjStephen G Waxman
Oct 30, 2007·Current Opinion in Pharmacology·Douglas S Krafte, Anthony W Bannon
Dec 7, 2007·Toxicon : Official Journal of the International Society on Toxinology·Yucheng XiaoSongping Liang
Aug 30, 2008·Molecular Pharmacology·William A SchmalhoferBirgit T Priest
Jun 27, 2009·Annals of Neurology·Tanya Z FischerStephen G Waxman
Sep 29, 2009·Nature Structural & Molecular Biology·Mirela MilescuKenton J Swartz
Jan 26, 2010·Trends in Pharmacological Sciences·Frank Bosmans, Kenton J Swartz
Jul 22, 2010·Cardiovascular Therapeutics·Carol Ann Remme, Connie R Bezzina
Dec 22, 2010·Journal of Cell Science·Gerrit van Meer, Anton I P M de Kroon
Jun 11, 2011·The Journal of Biological Chemistry·Yucheng XiaoTheodore R Cummins
Nov 2, 2012·Proceedings of the National Academy of Sciences of the United States of America·Catharina G FaberStephen G Waxman
Dec 13, 2012·Nature Reviews. Neuroscience·Sulayman D Dib-HajjStephen G Waxman
Jun 4, 2013·Toxicon : Official Journal of the International Society on Toxinology·Meichun DengSongping Liang
Feb 8, 2014·Nature Reviews. Cancer·Martin E Hemler
Dec 3, 2014·Proceedings of the National Academy of Sciences of the United States of America·Mihaela MihailescuStephen White
May 1, 2015·Journal of Medicinal Chemistry·Manuel de Lera Ruiz, Richard L Kraus
Aug 6, 2015·Nature Reviews. Neuroscience·Sulayman D Dib-HajjStephen G Waxman
Dec 6, 2016·Pharmacology & Therapeutics·Irina VetterMehdi Mobli
Jan 4, 2017·Scientific Reports·M FlinspachA D Wickenden

❮ Previous
Next ❯

Citations

Jan 12, 2021·Channels·Robert A Neff, Alan D Wickenden
Apr 2, 2021·Journal of Molecular Biology·Sigrid NorengJian Payandeh

❮ Previous
Next ❯

Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.